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Summary.-When large human breast cancers were assayed for oestrogen receptors
at multiple sites, 5-fold differences were found in the numbers of oestrogen receptors,
between the site within a tumour. This may result from variations in the cell:stroma
ratio from site to site. Such differences could be significant when receptor levels in
the tumour are low (<50 fmol oestradiol bound mg cytosol protein) since the classi-
fication distinction between hormone-sensitive and hormone-insensitive breast
cancers is based upon numbers of oestrogen receptors detected by the assay. This
problem might be remedied by assessment of the cell:stroma ratio in all assayed
tumours, and by the combination of the cytoplasmic oestrogen-receptor assay with
other hormone-receptor assays.
BREAST CANCERS have been classified as
hormone-sensitive or hormone-insensitive,
on the basis of results of an oestrogen-
receptor assay of cytosol fractions derived
from the tumour. The distinction between
these 2 classes of tumour is presently
dependent upon the number of binding
sites for oestradiol found in the tumour, a
value which varies with the method of
tumour processing (Hahnel & Vivian,
1975; Keightley et al., 1978) and also with
the particular section of the tumour which
is assayed (Braunsberg, 1975). This study
examines the inherent variability of the
oestrogen-receptor assay itself, and the
results of assays on multiple sites within
large breast cancers.
MATERIALS AND METHODS
Tissues.-Both human mammary-gland
tumours and human myometrium were used
in this study. Pre-menopausal myometrium
was used, as it is a relatively homogeneous
tissue, rich in oestrogen receptors.
Tissues were obtained fresh from the
operating theatre, immediately chilled on ice,
trimmed of extraneous tissue and divided
into 3-5 500mg portions in plastic containers.
* To whom all correspondeltce shouil(d be a(ldressed.
These were then snap-frozen in liquid N2
prior to the assay.
In some instances, 2-3 g of myometrium
were used to prepare a large pool of cytosol
fraction (in the manner outlined below).
Preparation of cytosol.-The tissue, after
snap-freezing in liquid N2, was powdered in a
prechilled stainless-steel chamber by sudden
percussion. To this powder was added 3 ml
of tris buffer (tris, 10 mM; ethylene diamine
tetra-acetate, 1 5 mm; pH 7-4) and the sus-
pension homogenized at 4°C with an Ultra
Turraxhomogenizer (JankeandKunkel) using
4 x 15s runs with 45 s ofcoolingbetween runs.
The homogenate was centrifuged for 1 h at
20,000 rev/min in a Beckman model L5-50
ultracentrifuge with a 5OTi rotor. The result-
ant supernatant cytosol fraction was drawn
off with a Pasteur pipette.
Oestrogen-receptor assay.-The method used
was based on that of Hawkins et al. (1975).
Portions (100 [t1) of the supernatant cytosol
fraction were incubated with various amounts
of non-radioactive oestradiol-17/ (0, 10, 30,
50, 70, 90, 2000 pg) and a fixed amount of
3H-oestradiol-17f7 (10 pg) (Amersham Searle;
sp. act.>80 Ci/mmol) in a total volume of
650 jul of tris buffer for 16 h at 4°C. At the
end of the incubation, 200 ,ul dextran-coated
charcoal (activated charcoal, 2-5 g; dextran-
T70, 250 g; tris buffer, 500 ml) was added toVARIABILITY IN OESTROGEN-RECEPTOR ASSAYS
each tube, incubated for 10 min and then
centrifuged at 3000 rev/min for 10 min. The
supernatant from each tube was decanted
into a scintillation vial with 7-5 ml of PCS
(Amersham Searle) and counted for 2 min in
a Searle Analytic Co. Mk III 6880 liquid-
scintillation system. After analysis of the
results as outlined by Hawkins et al. (1975) a
Scatchard plot was constructed, to give
values for the number of binding sites for
oestradiol and for the dissociation constant
for the oestradiol-receptor interaction (Scat-
chard, 1949). The results were expressed as
number of binding sites/mg cytosol protein,
the latter being measured by the method of
Lowry et al. (1951).
RESULTS
(1) Reproducibility of assay
(i) Cytosol.-Multiple assays were per-
formed on pooled myometrial cytosol
fractions. Results for 3 myometrial tissues
(Table I) indicate that the assay is con-
sistent, with only small variability in
binding-site numbers between assays of
the same cytosol fraction. The variability
of the dissociation constant is within
acceptable limits for such measurements.
(ii) Tissue.-When 5 adjacent portions
for each of 3 human myometria were
chosen for assay (Table II) variability in
the number of binding sites measured
increased markedly, although variability
in the dissociation constant remained in
the same range as for the pooled cytosol
fraction.
TABLE I.-Repeated oestrogen-receptor as-
says on 3 pooled myometrial cytosol
fractions
Assay No.
1
2
3
4
5
s.d.
v%
Pooled myometrial cytosol
fraction
1 2 3
Ns KD
50 0-18
49 0-25
51 0-31
55 0 25
56 0 30
52 0-26
3 0 05
6 20
Ns KD
26 0 65
25 0 58
27 0-81
26 0 77
20 0-27
25 0 62
3 0-21
11 35
Ns KD
37 0 58
38 0- 61
35 0 48
36 0 57
35 0-41
36 0-53
1 0-08
4 16
The number of binding sites (Ns: fmol/mg cytosol
protein) and the dissociation constant (KD; X 10-10
M) are shown, with the mean (x), standard deviation
(s.d.) and variability (v%=s.d/x x 100) for the 5
assays.
TABLE II.-Multiple oestrogen-receptor as-
says on 3 human myometria (see Table I
for abbreviations)
Myometrium
1
Assay No. Ns KD
1 34 0 37
2 31 0 26
3 36 0 -26
4 49 0 -32
5 46 0-36
X 39 0 33
s.d. 8 0 04
V% 20 13
differences. In tumours
receptors were detected
sites assayed.
2
Ns KD
32 0 73
26 0 82
36 0-52
37 0-60
23 0-52
31 0-64
6 0-12
20 21
3
Ns KD
24 0 75
47 0- 74
27 0 97
23 0 33
27 0 73
30 0 70
10 0 -23
33 33
6 and 7 oestrogen
in only one of the
(2) Multiple-site assays of human breast
cancer
Ostrogen-receptor assays were per-
formed on multiple sites of human mam-
mary-gland tumours when large receptor-
positive tumours became available. Re-
sults for 7 such large tumours are shown in
Table III. There was an increase in the
variability of the dissociation constants,
although the values measured were still
within the same range as those obtained
in myometrium. The binding-site numbers,
however, showed marked inter-site varia-
tion within each tumour, with up to 4-fold
DISCUSSION
The variability inherent in the oestro-
gen-receptor assay in this study is indica-
ted in the results obtained with pooled
cytosol fractions from human myome-
trium. These differences may be accounted
for by variability in pipetting, decanting,
and in the effectiveness of the charcoal in
removing unbound oestradiol.
The increased variability seen on assay
of separate portions of myometrium may
arisefrom variation in the ratio ofconnect-
ive tissue to receptor-containing cells.
This explanation is important in account-
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TABLE III.-Multiple oestrogen-receptor assays on 7 human mammary-gland tumour8.
Mammary gland tumour
1 2 3 4 5 6 7
Assay No. Ns KD Ns KD Ns KD Ns KD Ns KD Ns KD NS KD
1 202 0-13 60 0-17 59 0-27 139 0-26 990 2-54* 0 0 -
2 523 0 55 50 0-19 163 0 68 29 0-75 230 0-18 0 0
3 273 0-71 32 0 38 37 0-25 0 11 0-27
4 322 0-21 77 0-14 42 0-81 6 0-47
5 175 0 47
X 299 0-41 55 0-22 75 0-50
s.d. 138 0-24 19 0-11 59 0-29
V% 46 58 34 50 79 57
*Possibly an overestimate, as with the levels ofoestradiol used, saturation was not achieved.
ing for the large inter-site variability seen
in mammary-gland tumours.
Considerable variation in the cell:
stroma ratio has been found in mammary-
gland tumours, and a correlation between
this ratio and the number of binding sites
has been observed recently by Hawkins
et al. (1977). The increased variability in
the dissociation constant supports this ex-
planation, as the constitution ofthe cytosol
fraction influences the value obtained for
this parameter (Braunsberg, 1975).
Since the classification of tumours as
oestrogen-receptor-positive or oestrogen-
receptor-negative is dependent upon the
number of binding sites measured, the
presence of marked inter-site variation
in this number is important. In 5 of the
tumours assessed, despite wide variation,
the number of receptor sites measured in
all tumour sections was relatively high,
and the results of a single assay would
allow each tumour to be classified as
receptor-positive. Similar variability in
multiple assays of receptor-positive tum-
ours has been found by Braunsberg (1975)
and Hawkins et al. (1977). In 2 tumours,
however, receptors were found at only
one site, all others being negative. The
number ofreceptor sites, though low, could
be sufficient in some laboratories to allow
the tumour to be classified as oestrogen-
receptor-positive, on the results ofthat one
assay.
This study confirms the presence of
marked inter-site variation in the number
ofoestrogen-receptor sites withinanygiven
breast tumour. Inthe majority oftumours,
this variability did not affect the classifi-
cation ofreceptor status, but in 2 tumours
this variation was significant. Resolution
of this problem may be achieved by com-
bining:
(i) assessment of cell:stroma ratio at the
assayed site,
(ii) estimation of nuclear receptors for
oestrogen,
(iii) estimation of progesterone receptors.
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